Q/C Technologies, Inc. Proceeds from Issuance of Warrants
Q/C Technologies, Inc. (QCLS) reported Proceeds from Issuance of Warrants of $524.28 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-08-12
- Q/C Technologies, Inc. proceeds from issuance of warrants for the quarter ending 2026-06-30 was $13.10K.
- Q/C Technologies, Inc. proceeds from issuance of warrants for the quarter ending 2026-03-31 was $511.18K.
- Q/C Technologies, Inc. proceeds from issuance of warrants for the quarter ending 2025-12-31 was $9.03M.
- Q/C Technologies, Inc. proceeds from issuance of warrants for the quarter ending 2020-03-31 was $77.00.
- Q/C Technologies, Inc. proceeds from issuance of warrants for fiscal 2025 was $11.73M.
| Period end | Proceeds from Issuance of Warrants 0 month | Proceeds from Issuance of Warrants 0 month as first filed | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $524.28K 10-Q · filed 2026-08-12 | $9.55M derived: sum of 3 quarters · filed 2026-08-12 | |||
| 2026-03-31 | $511.18K 10-Q · filed 2026-05-15 | $9.54M derived: sum of 2 quarters · filed 2026-05-15 | ||||
| 2025-12-31 | $9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $11.73M 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $2.70M 10-Q · filed 2025-11-19 | |||||
| 2021-09-30 | $194.87K 10-Q/A · filed 2021-11-15 | |||||
| 2020-03-31 | $77.00 10-Q · filed 2020-05-15 | |||||
| 2019-12-09 | $80.00 10-Q · filed 2020-11-16 | $3.00 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |